Rigel Pharmaceuticals, Inc. (RIGL)
USD 16.15
(-6.32%)
USD 16.15
(-6.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 109.77 Million USD | -7.36% |
| 2022 | 118.49 Million USD | -20.02% |
| 2021 | 148.15 Million USD | 37.53% |
| 2020 | 107.72 Million USD | 84.52% |
| 2019 | 58.38 Million USD | 32.02% |
| 2018 | 44.22 Million USD | 205.83% |
| 2017 | -41.78 Million USD | 2.97% |
| 2016 | -43.06 Million USD | -26.92% |
| 2015 | -33.93 Million USD | 42.92% |
| 2014 | -59.44 Million USD | 12.81% |
| 2013 | -68.17 Million USD | 10.91% |
| 2012 | -76.52 Million USD | -1711.12% |
| 2011 | 4.75 Million USD | -96.2% |
| 2010 | 125 Million USD | 16566.67% |
| 2009 | 750 Thousand USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 12.6 Million USD | -62.36% |
| 2006 | 33.47 Million USD | 102.55% |
| 2005 | 16.52 Million USD | 249.17% |
| 2004 | 4.73 Million USD | -57.19% |
| 2003 | 11.05 Million USD | -29.98% |
| 2002 | 15.78 Million USD | 3.17% |
| 2001 | 15.3 Million USD | -26.34% |
| 2000 | 20.77 Million USD | 90.77% |
| 1999 | 10.89 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 27.5 Million USD | -14.04% |
| 2024 Q2 | 34.03 Million USD | 23.72% |
| 2023 Q2 | 25.81 Million USD | 2.86% |
| 2023 Q1 | 25.09 Million USD | -50.74% |
| 2023 Q3 | 26.86 Million USD | 4.09% |
| 2023 Q4 | 32 Million USD | 19.12% |
| 2023 FY | 109.77 Million USD | -7.36% |
| 2022 Q1 | 16.61 Million USD | -16.6% |
| 2022 Q3 | 22.16 Million USD | -23.01% |
| 2022 Q4 | 50.93 Million USD | 129.86% |
| 2022 Q2 | 28.78 Million USD | 73.25% |
| 2022 FY | 118.49 Million USD | -20.02% |
| 2021 Q2 | 26.13 Million USD | -67.61% |
| 2021 Q1 | 80.7 Million USD | 345.15% |
| 2021 FY | 148.15 Million USD | 37.53% |
| 2021 Q4 | 19.92 Million USD | -6.87% |
| 2021 Q3 | 21.39 Million USD | -18.15% |
| 2020 Q4 | 18.12 Million USD | -0.66% |
| 2020 FY | 107.72 Million USD | 84.52% |
| 2020 Q2 | 15.74 Million USD | -71.69% |
| 2020 Q1 | 55.6 Million USD | 265.3% |
| 2020 Q3 | 18.24 Million USD | 15.93% |
| 2019 FY | 58.38 Million USD | 32.02% |
| 2019 Q3 | 20.54 Million USD | 103.52% |
| 2019 Q2 | 10.09 Million USD | -19.34% |
| 2019 Q1 | 12.51 Million USD | -66.77% |
| 2019 Q4 | 15.22 Million USD | -25.92% |
| 2018 Q2 | 1.75 Million USD | 115.63% |
| 2018 FY | 44.22 Million USD | 205.83% |
| 2018 Q3 | 4.79 Million USD | 172.97% |
| 2018 Q4 | 37.66 Million USD | 685.43% |
| 2018 Q1 | -11.24 Million USD | 2.76% |
| 2017 Q2 | -11.52 Million USD | -31.07% |
| 2017 Q1 | -8.79 Million USD | -1.83% |
| 2017 FY | -41.78 Million USD | 2.97% |
| 2017 Q4 | -11.56 Million USD | -16.68% |
| 2017 Q3 | -9.9 Million USD | 14.02% |
| 2016 Q1 | -13.14 Million USD | -63.77% |
| 2016 FY | -43.06 Million USD | -26.92% |
| 2016 Q3 | -12.41 Million USD | -39.86% |
| 2016 Q4 | -8.63 Million USD | 30.43% |
| 2016 Q2 | -8.87 Million USD | 32.49% |
| 2015 FY | -33.93 Million USD | 42.92% |
| 2015 Q1 | -13.52 Million USD | -112.54% |
| 2015 Q4 | -8.02 Million USD | -220.4% |
| 2015 Q2 | -9.87 Million USD | 26.98% |
| 2015 Q3 | -2.5 Million USD | 74.63% |
| 2014 Q3 | -16.15 Million USD | 19.5% |
| 2014 Q1 | -16.86 Million USD | -37.19% |
| 2014 FY | -59.44 Million USD | 12.81% |
| 2014 Q2 | -20.06 Million USD | -18.93% |
| 2014 Q4 | -6.36 Million USD | 60.6% |
| 2013 Q1 | -20.31 Million USD | -2.79% |
| 2013 Q4 | -12.29 Million USD | 30.03% |
| 2013 FY | -68.17 Million USD | 10.91% |
| 2013 Q3 | -17.57 Million USD | 2.33% |
| 2013 Q2 | -17.99 Million USD | 11.43% |
| 2012 Q4 | -19.76 Million USD | 2.09% |
| 2012 FY | -76.52 Million USD | -1711.12% |
| 2012 Q1 | 750 Thousand USD | 0.0% |
| 2012 Q2 | 1.5 Million USD | 100.0% |
| 2012 Q3 | -20.18 Million USD | -1445.73% |
| 2011 Q3 | 4.35 Million USD | 1002.53% |
| 2011 Q2 | 395 Thousand USD | 0.0% |
| 2011 FY | 4.75 Million USD | -96.2% |
| 2011 Q1 | - USD | 100.0% |
| 2011 Q4 | - USD | -100.0% |
| 2010 FY | 125 Million USD | 16566.67% |
| 2010 Q4 | -125 Million USD | -272.93% |
| 2010 Q2 | 49.45 Million USD | 1416.62% |
| 2010 Q1 | 3.26 Million USD | 334.8% |
| 2010 Q3 | 72.28 Million USD | 46.15% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | 750 Thousand USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | 750 Thousand USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | -100.0% |
| 2008 Q1 | - USD | -100.0% |
| 2007 Q3 | - USD | -100.0% |
| 2007 FY | 12.6 Million USD | -62.36% |
| 2007 Q4 | 8 Million USD | 0.0% |
| 2007 Q2 | 1.95 Million USD | -26.02% |
| 2007 Q1 | 2.64 Million USD | -15.47% |
| 2006 Q4 | 3.12 Million USD | -48.95% |
| 2006 FY | 33.47 Million USD | 102.55% |
| 2006 Q1 | 9.89 Million USD | 64.4% |
| 2006 Q2 | 14.32 Million USD | 44.7% |
| 2006 Q3 | 6.12 Million USD | -57.22% |
| 2005 Q3 | 3.28 Million USD | -28.75% |
| 2005 Q4 | 6.02 Million USD | 83.42% |
| 2005 FY | 16.52 Million USD | 249.17% |
| 2005 Q1 | 2.61 Million USD | 138.0% |
| 2005 Q2 | 4.6 Million USD | 75.94% |
| 2004 FY | 4.73 Million USD | -57.19% |
| 2004 Q3 | 659 Thousand USD | -55.68% |
| 2004 Q1 | 1.48 Million USD | -29.39% |
| 2004 Q2 | 1.48 Million USD | 0.0% |
| 2004 Q4 | 1.1 Million USD | 66.92% |
| 2003 Q3 | 2.1 Million USD | -10.47% |
| 2003 Q1 | 4.49 Million USD | 21.54% |
| 2003 Q2 | 2.34 Million USD | -47.77% |
| 2003 Q4 | 2.1 Million USD | 0.14% |
| 2003 FY | 11.05 Million USD | -29.98% |
| 2002 Q4 | 3.7 Million USD | 1.29% |
| 2002 Q3 | 3.65 Million USD | -15.77% |
| 2002 Q2 | 4.33 Million USD | 5.83% |
| 2002 Q1 | 4.09 Million USD | 3.43% |
| 2002 FY | 15.78 Million USD | 3.17% |
| 2001 Q1 | 4.01 Million USD | 24.95% |
| 2001 FY | 15.3 Million USD | -26.34% |
| 2001 Q3 | 4.2 Million USD | 34.68% |
| 2001 Q4 | 3.96 Million USD | -5.8% |
| 2001 Q2 | 3.12 Million USD | -22.14% |
| 2000 Q4 | 3.21 Million USD | -3.78% |
| 2000 Q1 | 3.33 Million USD | 0.0% |
| 2000 Q2 | 3.33 Million USD | 0.0% |
| 2000 Q3 | 3.33 Million USD | 0.0% |
| 2000 FY | 20.77 Million USD | 90.77% |
| 1999 FY | 10.89 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -188.684% |
| Alkermes plc | 1.37 Billion USD | 92.015% |
| Agenus Inc. | 139.61 Million USD | 21.375% |
| Aptorum Group Limited | -1.11 Million USD | 9947.778% |
| Ardelyx, Inc. | 106.66 Million USD | -2.917% |
| Dyadic International, Inc. | 922.95 Thousand USD | -11793.512% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -421.21% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 62883.183% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 921.779% |
| Novavax, Inc. | 639.93 Million USD | 82.846% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 334.36% |
| Pyxis Oncology, Inc. | -2 Million USD | 5588.6% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 21342.932% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -476.443% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 248520.386% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 20929.602% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 211.765% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -13587.282% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 133968.293% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 18.849% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1294.639% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 213.225% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 92.768% |
| AlloVir, Inc. | -398 Thousand USD | 27680.905% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 54.401% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -25789.623% |
| Bicycle Therapeutics plc | -129.52 Million USD | 184.753% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -91376.667% |
| ChromaDex Corporation | 50.78 Million USD | -116.172% |
| Chimerix, Inc. | 324 Thousand USD | -33780.247% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 452.198% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 241.462% |
| CRISPR Therapeutics AG | 240.95 Million USD | 54.443% |
| Precision BioSciences, Inc. | 40.47 Million USD | -171.229% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 211.826% |
| Fortress Biotech, Inc. | 57.85 Million USD | -89.743% |
| Fortress Biotech, Inc. | 57.85 Million USD | -89.743% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -562.195% |
| ImmuCell Corporation | 4.39 Million USD | -2396.927% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 203.438% |
| Immix Biopharma, Inc. | -5468.00 USD | 2007634.748% |
| Incyte Corporation | 3.44 Billion USD | 96.81% |
| Innoviva, Inc. | 261.06 Million USD | 57.952% |
| IO Biotech, Inc. | -756 Thousand USD | 14620.106% |
| Jaguar Health, Inc. | 7.72 Million USD | -1321.181% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 16631.928% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 8.335% |
| ContextLogic Inc. | 59 Million USD | -86.054% |
| MiMedx Group, Inc. | 266.84 Million USD | 58.863% |
| MEI Pharma, Inc. | 49.32 Million USD | -122.539% |
| NextCure, Inc. | -3.68 Million USD | 3079.696% |
| Onconetix, Inc. | -1.12 Million USD | 9838.769% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 478.942% |
| Opthea Limited | 21.72 Thousand USD | -505295.948% |
| Psyence Biomedical Ltd. | -240.00 USD | 45738433.333% |
| Vaxcyte, Inc. | -75 Million USD | 246.363% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 191587.283% |
| Precigen, Inc. | 106 Thousand USD | -103458.491% |
| Pharming Group N.V. | 220.1 Million USD | 50.127% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -21214.951% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -10779.286% |
| PureTech Health plc | -1.6 Million USD | 6947.91% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 160.511% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 342.189% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 599.259% |
| Acelyrin, Inc. | -115 Thousand USD | 95553.913% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1092250.035% |
| Summit Therapeutics Inc. | -2.05 Million USD | 5454.732% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 19324.518% |
| Senti Biosciences, Inc. | -2.68 Million USD | 4191.39% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2609.751% |
| Elevation Oncology, Inc. | -39 Thousand USD | 281566.667% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2387.87% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2884.644% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -276.848% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -22031.452% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 199685.455% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -5.45% |
| Seer, Inc. | 7.02 Million USD | -1462.146% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2407.355% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -409.501% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 92741.635% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 76702.396% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -17924.959% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 8.883% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 65.004% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2195540.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -4164.646% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 216442.136% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -273.539% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 47415.517% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 22411.382% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1646.52% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 23232.053% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1055600.0% |
| Soligenix, Inc. | 97.31 Thousand USD | -112705.335% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1115.561% |
| Kura Oncology, Inc. | -849 Thousand USD | 13029.564% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 263.585% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 74774.83% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -10.837% |
| Autolus Therapeutics plc | -4.86 Million USD | 2355.435% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -165.239% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 65440.476% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -15.887% |
| GRI Bio, Inc. | 10.84 Million USD | -912.563% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4221.756% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1363.635% |
| IGM Biosciences, Inc. | -211.66 Million USD | 151.862% |
| INmune Bio, Inc. | 155 Thousand USD | -70720.645% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -77.226% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7387.569% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 17028.263% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 375081.212% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -27206.468% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 5599.599% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 35170.927% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -16.209% |
| Verastem, Inc. | -62 Thousand USD | 177151.613% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -4408.09% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 42158.238% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3526.429% |
| Histogen Inc. | 3.76 Million USD | -2812.497% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -18951.718% |
| Surrozen, Inc. | -27.23 Million USD | 503.129% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2136.964% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 9210.617% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 528.011% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -447.437% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 5544140.404% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1709.501% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 163619.09% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 29.084% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -75189.438% |
| Apollomics, Inc. | 127 Thousand USD | -86334.646% |
| Amarin Corporation plc | 165.54 Million USD | 33.689% |
| Mesoblast Limited | -9.81 Million USD | 1218.411% |
| Turnstone Biologics Corp. | 16.5 Million USD | -565.043% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 199.351% |
| Synaptogenix, Inc. | -6347.00 USD | 1729610.005% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 215339.216% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 31.973% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 93.755% |
| Better Therapeutics, Inc. | -2.72 Million USD | 4122.426% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 197.87% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 67.531% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 962337.027% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1853.546% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 10007.22% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1400.027% |
| Insmed Incorporated | 239.63 Million USD | 54.192% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2967.971% |
| OmniAb, Inc. | 14.66 Million USD | -648.428% |
| Alector, Inc. | -95.05 Million USD | 215.485% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 12.617% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 352.564% |
| Zai Lab Limited | 170.9 Million USD | 35.769% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -34.069% |
| Aura Biosciences, Inc. | -1.29 Million USD | 8576.602% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -84340.0% |
| Immunic, Inc. | -111 Thousand USD | 98993.694% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -592.393% |
| Veracyte, Inc. | 248.14 Million USD | 55.763% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.571% |
| FibroGen, Inc. | 128.9 Million USD | 14.842% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 19463220.567% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1040.885% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.77% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -28119.023% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 69.108% |
| TG Therapeutics, Inc. | 219.1 Million USD | 49.901% |
| Galecto, Inc. | -830 Thousand USD | 13325.542% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 8025.776% |
| Fortrea Holdings Inc. | 424 Million USD | 74.11% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 227.394% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 19460.141% |
| XBiotech Inc. | -1.74 Million USD | 6394.266% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 10007.22% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 336.216% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 245.328% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -49.547% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -553.288% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 71.784% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 321.105% |
| Vaxxinity, Inc. | -2.23 Million USD | 5013.697% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 66.405% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1069.388% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -348.947% |
| NexImmune, Inc. | -1.02 Million USD | 10809.756% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2032714.815% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1644.854% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.029% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 164362.948% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3191.298% |
| Ainos, Inc. | -253.73 Thousand USD | 43362.8% |
| Pluri Inc. | 322 Thousand USD | -33990.683% |
| Prothena Corporation plc | -129.2 Million USD | 184.962% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -117.698% |
| Celularity Inc. | 6.75 Million USD | -1525.048% |
| Rallybio Corporation | -150 Thousand USD | 73281.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 436.652% |
| MeiraGTx Holdings plc | 287 Thousand USD | -38148.084% |
| Omeros Corporation | -69.77 Million USD | 257.314% |
| Humacyte, Inc. | -76.55 Million USD | 243.399% |
| Immunocore Holdings plc | 248.39 Million USD | 55.807% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 823.66% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -75.967% |
| Blueprint Medicines Corporation | 236.58 Million USD | 53.601% |
| CalciMedica, Inc. | -58 Thousand USD | 189362.069% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 7797.896% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -277.808% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3959.775% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 455.652% |
| Pulmatrix, Inc. | -8.22 Million USD | 1435.426% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 9482.222% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 27611.779% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 127.526% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3854.914% |
| Cytokinetics, Incorporated | -322.59 Million USD | 134.028% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12633.02% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 32291.202% |
| Vor Biopharma Inc. | -3.49 Million USD | 3243.528% |
| Roivant Sciences Ltd. | 109.23 Million USD | -0.492% |
| Evogene Ltd. | 1.39 Million USD | -7746.462% |
| ProKidney Corp. | -3.16 Million USD | 3563.932% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 349.982% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1500.875% |
| CorMedix Inc. | -205.56 Thousand USD | 53500.92% |
| BioLineRx Ltd. | 1.1 Million USD | -9807.22% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 239.533% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 332742.424% |
| Atai Life Sciences N.V. | -5000.00 USD | 2195540.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 90181.159% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 114445.833% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 8002.952% |
| Sagimet Biosciences Inc. | 2 Million USD | -5388.6% |
| MediciNova, Inc. | 979.7 Thousand USD | -11104.597% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 230.187% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 116193.279% |
| GeoVax Labs, Inc. | -20.72 Million USD | 629.768% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 55.11% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2712.997% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 87.416% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1378.212% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 35510.323% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 914866.667% |
| Absci Corporation | -41.84 Million USD | 362.305% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2195540.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 243.731% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4560.463% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 48.641% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 11765.462% |
| Allakos Inc. | -6.14 Million USD | 1887.526% |
| Imunon, Inc. | -720 Thousand USD | 15346.005% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 259.099% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 76.934% |
| BioAtla, Inc. | -103.73 Million USD | 205.824% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 962337.027% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 61769.663% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 145.207% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 35396.463% |
| XOMA Corporation | 3.86 Million USD | -2743.098% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 256.627% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -642.004% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4696.817% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -780.995% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 378624.138% |
| Viridian Therapeutics, Inc. | -1 Million USD | 10990.079% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -844399900.0% |
| Akari Therapeutics, Plc | -4000.00 USD | 2744400.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 82.764% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -56277.755% |
| UroGen Pharma Ltd. | 73.35 Million USD | -49.651% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 511.223% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -945395.263% |
| Orgenesis Inc. | -5.72 Million USD | 2017.415% |
| Entera Bio Ltd. | -56 Thousand USD | 196121.429% |
| GH Research PLC | -315 Thousand USD | 34948.254% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 58180.423% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 21008.952% |
| Xencor, Inc. | -85.26 Million USD | 228.75% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 49775.758% |
| Replimune Group, Inc. | -2.65 Million USD | 4234.539% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 11063.649% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 38.276% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -56277.755% |
| Portage Biotech Inc. | -54 Thousand USD | 203381.481% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 116193.279% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 29217.241% |
| OncoCyte Corporation | 413 Thousand USD | -26479.177% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2442191.212% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 49446946.847% |
| Purple Biotech Ltd. | -196 Thousand USD | 56106.122% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1124.041% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1022.184% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1150.957% |
| HilleVax, Inc. | -2.15 Million USD | 5191.466% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 113267.01% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 731718.235% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 16532.934% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 477369.565% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1462525.528% |
| Savara Inc. | -44.26 Million USD | 348.005% |
| Curis, Inc. | 9.81 Million USD | -1018.867% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3863.572% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 88066.792% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 6448.872% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 48245.614% |
| BeiGene, Ltd. | 2.07 Billion USD | 94.72% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 4026.178% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 127.466% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -93.642% |
| Erasca, Inc. | -3.73 Million USD | 3041.372% |
| bluebird bio, Inc. | -4.03 Million USD | 2823.871% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 389114.104% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 94.236% |
| DBV Technologies S.A. | 15.72 Million USD | -597.94% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 389114.104% |
| Moderna, Inc. | 2.15 Billion USD | 94.906% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 12096.94% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1271.122% |
| Molecular Templates, Inc. | 50.39 Million USD | -117.823% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 20579.851% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 17.951% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1864.256% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 379.013% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 198.78% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3159.42% |
| MacroGenics, Inc. | 50.52 Million USD | -117.254% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1900.131% |
| Prime Medicine, Inc. | -147.9 Million USD | 174.218% |
| Aditxt, Inc. | -111.66 Thousand USD | 98409.153% |
| Adagene Inc. | 18.11 Million USD | -506.09% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -22394.262% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 21.704% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 30.452% |
| SciSparc Ltd. | 2.19 Million USD | -4898.725% |
| Vericel Corporation | 135.57 Million USD | 19.033% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 438329.071% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 354408.954% |
| Generation Bio Co. | -73.91 Million USD | 248.519% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 25219.451% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -100.978% |
| Invivyd, Inc. | -2.02 Million USD | 5512.821% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 136.488% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 106223.475% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -13.909% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -11.684% |
| ADMA Biologics, Inc. | 88.21 Million USD | -24.433% |
| Clene Inc. | 533 Thousand USD | -20495.122% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -355.312% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 11570.428% |
| GeoVax Labs, Inc. | -20.72 Million USD | 629.768% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -5421.73% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 56591.488% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -120.404% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1647.829% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 13230.622% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -31.597% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -150042.248% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -106.486% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 163.383% |
| Trevena, Inc. | 1.45 Million USD | -7444.467% |
| Surrozen, Inc. | -27.23 Million USD | 503.129% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 31196.884% |
| Cingulate Inc. | -582.91 Thousand USD | 18931.465% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 354203.226% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 657.247% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1450192.47% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 12559.932% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 83.874% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 11210.526% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 194931.564% |
| Kronos Bio, Inc. | 1.37 Million USD | -7900.875% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 304.547% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 37693.151% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 22579.798% |
| ImmunityBio, Inc. | -17.89 Million USD | 713.594% |
| Korro Bio, Inc. | -3.63 Million USD | 3124.022% |
| Kineta, Inc. | 5.43 Million USD | -1920.468% |
| BioVie Inc. | -229.37 Thousand USD | 47956.585% |
| Codexis, Inc. | 57.33 Million USD | -91.461% |
| Celularity Inc. | 6.75 Million USD | -1525.048% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2635.41% |
| Celcuity Inc. | -142.77 Thousand USD | 76986.224% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -216883.594% |
| Cibus, Inc. | 1.42 Million USD | -7619.55% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 29450.802% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 578.956% |
| IN8bio, Inc. | -2.5 Million USD | 4489.124% |
| Kodiak Sciences Inc. | -25.94 Million USD | 523.062% |
| Annexon, Inc. | -3.26 Million USD | 3460.024% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 5470.45% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 363.009% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -17051.875% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 85.9% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 36.531% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5877.474% |
| Arcellx, Inc. | 108.27 Million USD | -1.379% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 439.127% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -38.594% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 618.967% |
| Moolec Science SA | -143.3 Thousand USD | 76700.258% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 359.398% |
| Geron Corporation | -123.5 Million USD | 188.882% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3239.58% |
| Royalty Pharma plc | 1.79 Billion USD | 93.881% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 256.616% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3039191.916% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -47340.047% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 198.526% |
| Humacyte, Inc. | -76.55 Million USD | 243.399% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 11665.003% |
| 89bio, Inc. | -273 Thousand USD | 40309.524% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 8832.856% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 13044.811% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 89345.528% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -9709.83% |
| Notable Labs, Ltd. | 113 Thousand USD | -97043.363% |
| Liquidia Corporation | 14.6 Million USD | -651.863% |
| Mustang Bio, Inc. | -2.22 Million USD | 5033.573% |
| Immunovant, Inc. | -231 Thousand USD | 47620.346% |
| Quantum-Si incorporated | 488 Thousand USD | -22394.262% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 297.577% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 366006.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -5795.381% |
| Acasti Pharma Inc. | -11 Thousand USD | 998027.273% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 53747.546% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 17028.263% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 165.531% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -9575.122% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 28911.549% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 5706.333% |
| PepGen Inc. | -1.18 Million USD | 9371.284% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 86534.646% |
| United Therapeutics Corporation | 2.07 Billion USD | 94.697% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 579.417% |
| Solid Biosciences Inc. | -76.56 Million USD | 243.375% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 133023.241% |
| Immuneering Corporation | -764.13 Thousand USD | 14465.468% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -165558.578% |
| Belite Bio, Inc | -399 Thousand USD | 27611.779% |
| XOMA Corporation | 3.86 Million USD | -2743.098% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 647.874% |
| Bionomics Limited | -434.44 Thousand USD | 25366.947% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10320.857% |
| uniQure N.V. | 2.21 Million USD | -4855.847% |
| Cassava Sciences, Inc. | -89.42 Million USD | 222.756% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 219.228% |
| Forte Biosciences, Inc. | -9000.00 USD | 1219788.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 13246.347% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 25219.451% |
| Altimmune, Inc. | -65.37 Million USD | 267.916% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 69.679% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10320.857% |
| Compugen Ltd. | 31.45 Million USD | -248.981% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29748.084% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -347.757% |
| Benitec Biopharma Inc. | 108 Thousand USD | -101540.741% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 140833.333% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 9224.855% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 6124.808% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 92345.378% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 9224.855% |
| Instil Bio, Inc. | -4.75 Million USD | 2408.074% |
| argenx SE | 1.1 Billion USD | 90.097% |
| Immunome, Inc. | -8.9 Million USD | 1332.424% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5908.042% |
| Verona Pharma plc | -679.62 Thousand USD | 16251.872% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 62826.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4702.6% |
| CervoMed Inc. | -1.29 Million USD | 8585.599% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4660.532% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2397.928% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -4342.412% |
| Moolec Science SA | -143.3 Thousand USD | 76700.258% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 27002.924% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 4208.959% |
| AnaptysBio, Inc. | 14.78 Million USD | -642.656% |
| Design Therapeutics, Inc. | -537 Thousand USD | 20541.713% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 25807.728% |
| NeurAxis, Inc. | 2.15 Million USD | -4989.804% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -5015.191% |
| Lumos Pharma, Inc. | 2 Million USD | -5369.457% |
| Achilles Therapeutics plc | -4.73 Million USD | 2420.14% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 62826.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 103976.981% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -246.735% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12633.02% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 10736.822% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 341.003% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -255183.721% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 13454.258% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 834360.526% |
| Palisade Bio, Inc. | 246 Thousand USD | -44522.764% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 332742.424% |
| Beam Therapeutics Inc. | -59.67 Million USD | 283.959% |
| Neurogene Inc. | -3.26 Million USD | 3465.175% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 21.217% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3073.239% |
| Sesen Bio, Inc. | 40 Million USD | -174.43% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 37060.269% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2825.875% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1247.522% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -679.631% |
| Athira Pharma, Inc. | -969 Thousand USD | 11428.38% |
| Vaccinex, Inc. | -16 Million USD | 785.904% |
| HCW Biologics Inc. | -574.82 Thousand USD | 19196.628% |
| XOMA Corporation | 3.86 Million USD | -2743.098% |
| Nektar Therapeutics | 53.47 Million USD | -105.266% |
| Arvinas, Inc. | 71.8 Million USD | -52.886% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 231.525% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 274.866% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 34190.683% |
| Rezolute, Inc. | -36 Thousand USD | 305022.222% |
| Clene Inc. | 533 Thousand USD | -20495.122% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 8549321.184% |
| BeyondSpring Inc. | 1.75 Million USD | -6169.103% |
| Synlogic, Inc. | -1.92 Million USD | 5805.405% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 296781.081% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1833.607% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29748.084% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 678.875% |
| Krystal Biotech, Inc. | 47.6 Million USD | -130.589% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 22.198% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2084.517% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 4339.58% |
| MannKind Corporation | 136.19 Million USD | 19.398% |
| Ikena Oncology, Inc. | -50.49 Million USD | 317.405% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -0.88% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2603.352% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 43660.317% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2195540.0% |
| Legend Biotech Corporation | 140.92 Million USD | 22.108% |
| Mural Oncology plc | -2.56 Million USD | 4376.276% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 20022.323% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 109872.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -428.92% |
| REGENXBIO Inc. | 53.02 Million USD | -107.004% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2149.15% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 57161.468% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 6437.875% |
| Vaxart, Inc. | -60.76 Million USD | 280.656% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 41873.347% |
| Cellectis S.A. | 18 Thousand USD | -609744.444% |
| Longeveron Inc. | 221 Thousand USD | -49570.588% |
| Repare Therapeutics Inc. | -80.07 Million USD | 237.095% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 89.957% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 8583.153% |
| Revolution Medicines, Inc. | -399.66 Million USD | 127.466% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 313734.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -223924.49% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.725% |
| Denali Therapeutics Inc. | -93.34 Million USD | 217.598% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 438329.071% |
| Veru Inc. | 7.56 Million USD | -1350.873% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 72796.689% |
| Cingulate Inc. | -582.91 Thousand USD | 18931.465% |
| Passage Bio, Inc. | -3.72 Million USD | 3050.067% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 911524.776% |
| Exicure, Inc. | -1.42 Million USD | 7814.125% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 28761.097% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3961.117% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 21511.616% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -61.131% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 73473.572% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 285.407% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -27974.68% |
| OmniAb, Inc. | 14.66 Million USD | -648.428% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -449.052% |
| Lipocine Inc. | -2.85 Million USD | 3950.544% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 6056.158% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2024.137% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7387.569% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -45.749% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 168980.0% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -30.222% |
| Ocugen, Inc. | -33.53 Million USD | 427.316% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3571.6% |
| Q32 Bio Inc. | 578 Thousand USD | -18891.696% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 41523.396% |
| Alumis Inc. Common Stock | -1.28 Million USD | 8649.221% |
| Equillium, Inc. | 35.95 Million USD | -205.278% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 6530.697% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -21824.626% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2655445.912% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 42483.012% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -25868.508% |
| Dominari Holdings Inc. | 2.03 Million USD | -5283.619% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 59930.709% |
| vTv Therapeutics Inc. | -13.59 Million USD | 907.444% |
| Bio-Techne Corporation | 773.07 Million USD | 85.801% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -533.824% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 76.177% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 9490.248% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 557.765% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -838.463% |
| Nkarta, Inc. | -5.86 Million USD | 1970.37% |
| BioCardia, Inc. | -7.24 Million USD | 1614.305% |
| Iterum Therapeutics plc | -1.75 Million USD | 6372.686% |